Roach ES. Neurocutaneous syndromes. Pediatr Clin North Am. 1992;39:591–620.
Article CAS PubMed Google Scholar
Kanada KN, Merin MR, Munden A, Friedlander SF. A prospective study of cutaneous findings in newborns in the United States: correlation with race, ethnicity, and gestational status using updated classification and nomenclature. J Pediatr. 2012;161:240–5.
Tallman B, Tan OT, Morelli JG, Piepenbrink J, Stafford TJ, Trainor S, et al. Location of port-wine stains and the likelihood of ophthalmic and/or central nervous system complications. Pediatrics. 1991;87:323–7.
Article CAS PubMed Google Scholar
Sanchez-Carpintero I, Mihm MC, Mizeracki A, Waner M, North PE. Epithelial and mesenchymal hamartomatous changes in a mature port-wine stain: morphologic evidence for a multiple germ layer field defect. J Am Acad Dermatol. 2004;50:608–12.
Poliner A, Fernandez Faith E, Blieden L, Kelly KM, Metry D. Port-wine birthmarks: update on diagnosis, risk assessment for sturge-weber syndrome, and management. Pediatr Rev. 2022;43:507–16.
Van Trigt WK, Kelly KM, Hughes CCW. GNAQ mutations drive port wine birthmark-associated Sturge-Weber syndrome: a review of pathobiology, therapies, and current models. Front Hum Neurosci. 2022;16:1006027.
Article PubMed PubMed Central Google Scholar
Sabeti S, Ball KL, Burkhart C, Eichenfield L, Fernandez Faith E, Frieden IJ, et al. Consensus statement for the management and treatment of port-wine birthmarks in Sturge–Weber syndrome. JAMA Dermatol. 2021;157:98–104.
Article PubMed PubMed Central Google Scholar
Shirley MD, Tang H, Gallione CJ, Baugher JD, Frelin LP, Cohen B, et al. Sturge-weber syndrome and port-wine stains caused by somatic mutation in GNAQ. N Engl J Med. 2013;368:1971–9.
Article CAS PubMed PubMed Central Google Scholar
Kunimoto K, Yamamoto Y, Jinnin M. ISSVA classification of vascular anomalies and molecular biology. Int J Mol Sci. 2022;23:2358.
Article CAS PubMed PubMed Central Google Scholar
Thorpe J, Frelin LP, McCann M, Pardo CA, Cohen BA, Comi AM, et al. Identification of a mosaic activating mutation in GNA11 in atypical Sturge-Weber syndrome. J Invest Dermatol. 2021;141:685–8.
Article CAS PubMed Google Scholar
Polubothu S, Al-Olabi L, del Carmen BM, Chacko A, Eleftheriou G, Glover M, et al. GNA11 mutation as a cause of Sturge-Weber syndrome: expansion of the phenotypic spectrum of Gα/11 mosaicism and the associated clinical diagnoses. J Invest Dermatol. 2020;140:1110–3.
Article CAS PubMed PubMed Central Google Scholar
Wang S, Pan J, Zhao M, Wang X, Zhang C, Li T, et al. Characteristics, surgical outcomes, and influential factors of epilepsy in Sturge-Weber syndrome. Brain. 2022;145:3431–43.
Nguyen V, Hochman M, Mihm MC, Nelson JS, Tan W. The pathogenesis of port wine stain and Sturge Weber syndrome: complex interactions between genetic alterations and aberrant MAPK and PI3K activation. Int J Mol Sci. 2019;20:2243.
Article CAS PubMed PubMed Central Google Scholar
Okudaira Y, Arai H, Sato K. Hemodynamic compromise as a factor in clinical progression of Sturge-Weber syndrome. Childs Nerv Syst. 1997;13:214–9.
Article CAS PubMed Google Scholar
Aylett SE, Neville BG, Cross JH, Boyd S, Chong WK, Kirkham FJ. Sturge-Weber syndrome: cerebral haemodynamics during seizure activity. Dev Med Child Neurol. 1999;41:480–5.
Article CAS PubMed Google Scholar
Yeom SE, Comi AM. Updates on Sturge-Weber syndrome. Stroke. 2022;53:3769–79.
Knöpfel N, Zecchin D, Richardson H, Polubothu S, Barberan-Martin S, Cullup T, et al. GNAQ/GNA11 mosaicism is associated with abnormal serum calcium indices and microvascular neurocalcification .J Invest Dermatol. 2024;144:820–32.e9.
Zecchin D, Knöpfel N, Gluck AK, Stevenson M, Sauvadet A, Polubothu S, et al. GNAQ/GNA11 mosaicism causes aberrant calcium signaling susceptible to targeted therapeutics. J Invest Dermatol. 2024;144:811–9.e4.
Article CAS PubMed PubMed Central Google Scholar
Moccia F, Negri S, Shekha M, Faris P, Guerra G. Endothelial Ca2+ signaling, angiogenesis and vasculogenesis: just what it takes to make a blood vessel. Int J Mol Sci. 2019;20:3962.
Article CAS PubMed PubMed Central Google Scholar
Comi AM. Presentation, diagnosis, pathophysiology, and treatment of the neurological features of Sturge-Weber syndrome. Neurologist. 2011;17:179–84.
Article PubMed PubMed Central Google Scholar
Yeom S, Cohen B, Weiss CR, Montano C, Wohler E, Sobreira N, et al. Genetic testing in the evaluation of individuals with clinical diagnosis of atypical Sturge-Weber syndrome. Am J Med Genet A. 2023;191:983–94.
Article CAS PubMed Google Scholar
Setty BA, Wusik K, Hammill AM. How we approach genetics in the diagnosis and management of vascular anomalies. Pediatr Blood Cancer. 2022;69(Suppl 3):e29320.
Sabeti S, Ball KL, Bhattacharya SK, Bitrian E, Blieden LS, Brandt JD, et al. Consensus statement for the management and treatment of Sturge-Weber syndrome: neurology, neuroimaging, and ophthalmology recommendations. Pediatr Neurol. 2021;121:59–66.
Article PubMed PubMed Central Google Scholar
Sujansky E, Conradi S. Outcome of Sturge-Weber syndrome in 52 adults. Am J Med Genet. 1995;57:35–45.
Article CAS PubMed Google Scholar
Waelchli R, Aylett SE, Robinson K, Chong WK, Martinez AE, Kinsler VA. New vascular classification of port-wine stains: improving prediction of Sturge-Weber risk. Br J Dermatol. 2014;171:861–7.
Article CAS PubMed PubMed Central Google Scholar
Dymerska M, Kirkorian AY, Offermann EA, Lin DD, Comi AM, Cohen BA. Size of facial port-wine birthmark may predict neurologic outcome in sturge-weber syndrome. J Pediatr. 2017;188:205–9.e1.
Article PubMed PubMed Central Google Scholar
Kaseka ML, Bitton JY, Décarie JC, Major P. Predictive factors for epilepsy in pediatric patients with Sturge-Weber syndrome. Pediatr Neurol. 2016;64:52–8.
Boos MD, Bozarth XL, Sidbury R, Cooper AB, Perez F, Chon C, et al. Forehead location and large segmental pattern of facial port-wine stains predict risk of Sturge-Weber syndrome. J Am Acad Dermatol. 2020;83:1110–7.
Sánchez-Espino LF, Ivars M, Antoñanzas J, Baselga E. Sturge-Weber syndrome: a review of pathophysiology, genetics, clinical features, and current management approache. Appl Clin Genet. 2023;16:63–81.
Article PubMed PubMed Central Google Scholar
Dutkiewicz AS, Ezzedine K, Mazereeuw-Hautier J, Lacour JP, Barbarot S, Vabres P, et al. A prospective study of risk for Sturge-Weber syndrome in children with upper facial port-wine stain. J Am Acad Dermatol. 2015;72:473–80.
Gupta D, Hochman M. Capillary malformation. In: Perkins JA, Balakrishnan K, editors. Evidence-based management of head and neck vascular anomalies. Cham: Springer International Publishing; 2018. p. 149–59.
Jordan M, Carmignac V, Sorlin A, Kuentz P, Albuisson J, Borradori L, et al. Reverse phenotyping in patients with skin capillary malformations and mosaic GNAQ or GNA11 mutations defines a clinical spectrum with genotype-phenotype correlation. J Invest Dermatol. 2020;140:1106-1110.e2.
Article CAS PubMed Google Scholar
Fry MV, Williams BK, Kim HJ, Di Nicola M. Choroidal melanoma in phakomatosis pigmentovascularis with overlapping sturge-weber syndrome and Klippel-Trenaunay syndrome. Retin Cases Brief Rep. 2023;17:130–3.
Van Raamsdonk CD, Bezrookove V, Green G, Bauer J, Gaugler L, O’Brien JM, et al. Frequent somatic mutations of GNAQ in uveal melanoma and blue naevi. Nature. 2009;457:599–602.
Hassanpour K, Nourinia R, Gerami E, Mahmoudi G, Esfandiari H. Ocular manifestations of the Sturge-Weber syndrome. J Ophthalmic Vis Res. 2021;16:415–31.
PubMed PubMed Central Google Scholar
Sharan S, Swamy B, Taranath DA, Jamieson R, Yu T, Wargon O, et al. Port-wine vascular malformations and glaucoma risk in Sturge-Weber syndrome. J Am Assoc Pediatr Ophthalmol Strabismus. 2009;13:374–8.
Hennedige AA, Quaba AA, Al-Nakib K. Sturge-Weber syndrome and dermatomal facial port-wine stains: Incidence, association with glaucoma, and pulsed tunable dye laser treatment effectiveness. Plast Reconstr Surg. 2008;121:1173–80.
留言 (0)